The #FDA has approved @Boehringer ’s #Cyltezo as an interchangeable #biosimilar for @Amgen ‘s #Humira https://t.co/67OU6WIPLd
The #FDA has approved @Boehringer ’s #Cyltezo as an interchangeable #biosimilar for @Amgen ‘s #Humira https://t.co/67OU6WIPLd